India's Dr. Lal Pathlabs up on Q2 profit jump

Dr. Lal PathLabs

02/11/2023 09:11

** Shares of Dr. Lal Pathlabs  DLPA.NS  up as much as 2.9% to
2,450 rupees
    ** Medical diagnostics firm posts 52.4% YoY rise in Sept-qtr
consol net profit to 1.09 bln rupees ($13.10 million) 
    ** Rev from ops up nearly 13% YoY to 6.01 bln rupees
    ** Over 376,000 shares change hands by 2:31 p.m. IST, 1.5x
the 30-day moving avg
    ** Four of the 18 analysts covering the stock have "buy" or
"strong buy" rating, one rates it as "hold", while 13 recommend
"sell" or "strong sell"; median PT is 2,130 rupees - LSEG data
    ** Stock currently up nearly 1%, pushing YTD gains to about
6.2%

($1 = 83.2277 Indian rupees)

 (Reporting by Navamya Ganesh Acharya in Bengaluru)
 ((Navamya.GaneshAcharya@thomsonreuters.com; +91 8805175330 ;))